Article Details

Roche multiple sclerosis subcutaneous injection: late-breaking data

Retrieved on: 2023-10-11 16:23:45

Tags for this article:

Click the tags to see associated articles and topics

Roche multiple sclerosis subcutaneous injection: late-breaking data. View article details on hiswai:

Excerpt

Data for Roche's RMS/PPMS subcutaneous injection. The new late-breaking data from the Phase III OCARINA II study showed that OCREVUS subcutaneous ...

Article found on: www.europeanpharmaceuticalreview.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up